Vedolizumab Induces Endoscopic and Histologic Remission in Patients With Crohn’s DiseaseMark Löwenberg, Geert D’Haens, Denis Franchimont et al.|Gastroenterology|2019Cited by 127
Personalized extended interval dosing of natalizumab in MSZoé L. E. van Kempen, Joep Killestein, E.L.J. Hoogervorst et al.|Neurology|2020Cited by 56